Effect of 5α-reductase inhibitors on the efficiency of thulium:yttrium-aluminium-garnet (RevoLix®) vaporesection for treating benign prostatic hyperplasia
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.